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Purpose: The severity of obstructive sleep apnoea (OSA) ranges from mild or moderate to
severe sleep apnoea. However, there is no information available on the clinical character-
istics associated with cases involving more than 100 events per hour. This is a preliminary
report and our goal was to characterise the demographics and sleep characteristics of
patients with Extreme OSA and compare with patients with sleep apnoea of lesser severity.
We hypothesised that patients with Extreme OSA (AHI4100) is associated with an
increased comorbidities and/or risk factors.
Methods: We carried out a case-control study on male patients with OSA who were seen in a
private hospital in Lima, Peru between 2006 and 2012. Cases were identiﬁed if their apnoea/
hypopnea index (AHI) was higher than 100 (Extreme OSA), and four controls were selected per
case: two with 15–29 AHI and two with 30–50 AHI, matched according to case diagnosis dates.
We evaluated demographic, past medical history, and oxygen saturation variables
Results: We identiﬁed 19 cases that were matched with 54 controls. In the multivariate model,
only arterial hypertension, neck circumference, age, and over 10% in SatO2Hbr90% in total
sleep time (T90) were associated with Extreme OSA. Arterial hypertension had an OR¼6.31
(CI95%: 1.71–23.23) of Extreme OSA. Each 5-cm increment in neck circumference was associated
with an increase of OR¼4.34 (CI95%: 1.32–14.33), while T90410% had an OR¼19.68 (CI95%: 4.33–
89.49). Age had a marginal relevance (OR¼0.95; CI95%: 0.92–0.99)
Conclusion: Our results suggest that arterial hypertension, neck circumference, and over 10%
SatO2Hbr90% in total sleep time were associated with a higher probability of Extreme OSA.
We recommend investigators to study this population of Extreme OSA looking for an early dia-
gnosis and the identiﬁcation of prognostic factors in comparison withmoderate to severe levels.
& 2015 Brazilian Association of Sleep. Production and Hosting by Elsevier B.V. This is an open
access article under the CC BY-NC-ND license
(http://creativecommons.org/licenses/by-nc-nd/4.0/).ep. Production and Hosting by Elsevier B.V. This is an open access article under the CC BY-
licenses/by-nc-nd/4.0/).
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Obstructive sleep apnoea (OSA) is a common disease, with a
prevalence of 3–5% symptomatic and 24–26% asymptomatic
patients [1–3]. OSA is caused by episodic upper airway
obstruction which occurs during sleep. Obstruction can be
total (apnoea) or partial (hypopnea), and can occur several
times during sleep [4]. The Apnoea–Hypopnea Index (AHI) is
used to classify the severity of the illness: mild AHI 5 to o15;
moderate 15 to o30; and severe 30 or more [5].
It is well known that patients with severe OSA have higher
morbidity and mortality rates compared to those with mild or
moderate levels [6,7]. This is relevant mainly in patients with
arterial hypertension, coronary disease and stroke [8,9],
ventricular dysfunction [10]. For this reason, severe cases
require more immediate treatment [11,12]. However, severe
OSA includes a very broad spectrum in a group of patients
with an AHIZ30, and morbid-mortality outcomes could be
different in patients with different degrees of severe disease.
In a preliminary study, Jurcevic et al. postulated that
patients with AHIZ60 had increased mortality and more
severe clinical parameters [13]. The study compared them to
patients with AHIo60. Thus, the cut-off point included the
conventional severity category. In this scenario, it is very
complicated to differentiate the added effect of the proposed
new category. Our goal was to identify the clinical and
polysomnographic association between moderate to severe
OSA with an arbitrary category known as Extreme OSA,
deﬁned as an AHI4100. We hypothesised that patients with
Extreme OSA (AHI4100) is associated with an increased
comorbidities and/or risk factors in comparison with moder-
ate to severe levels.2. Methodology
2.1. Study design
We carried out a case-control study. The records came from a
primary database study that aimed to describe all patients
evaluated at a sleep laboratory operating in a private hospital
(Clínica Anglo Americana) in Lima, Peru.2.2. Population
We included all cases with an Apnoea–Hypopnea Index (AHI)
4100 events per hour. We named them Extreme Obstructive
Sleep Apnoea (X-OSA case group), and compared with
patients who met the criteria for moderate to severe sleep
apnoea (control group). We randomly selected four controls
per case: two with 15–29 AHI (moderate control group) and
two with 30–50 AHI (severe control group). Cases and controls
were matched according to the polysomnographic study date
of each case. All cases and controls patients had less than 5%
of central respiratory events. The period considered for
controls was up to three months prior to the index case.
We excluded females and controls with sleep disease
comorbidity.2.3. Polysomnography
All patients were diagnosed with OSA undergo polisomnogra-
phy. For acquisition, we used the Easy II, Easy III from Cadwell
Inc., and Neuro BE Light devices. The arrangements were: F2-M1,
C2-M1, O2-M1, E1-M2, E2-M2, chin electromyography, airﬂow
with thermistor and nasal cannula pressure, snoring micro-
phone in the pre tracheal area, thoracic and abdominal effort,
pulse oxymetry, ECG with DII derivation, body position sensor
and electromyography of both anterior tibia muscles. The PSG
acquisition was a supervised level I study in accordance with
the American Sleep Disorders Association (ASDA) classiﬁcation
[14]. The scorning criteria for staging systemwas done according
to the AASM Manual [15]. Arousal criteria was deﬁning accord-
ing to ASDA criteria [16], and we used the Sleep Spanish Group
criteria for qualiﬁcation of the respiratory events [17].
Two protocols were used for polysomnographic recordings:
all-night and split-night studies. Although differences have
been identiﬁed in the selection of patients for a type of
polysomnographic recording, no variations have been reported
in oximeter measurements and AHI results [18,19]. In accor-
dance with these papers, both acquisitions were combined.
2.4. Variables
The clinical and polysomnographic variables included for the
analysis were: age (years), weight (kg), height (m), body mass
index (BMI: kg/m2), neck circumference (cm), Mallampati
classiﬁcation, blood pressure, and the score on the Epworth
sleepiness scale adapted to Peruvian adults [20]. Oxygen
saturation parameters included nadir saturation, and total
sleep time in oxygen saturationr90% (T90).
We deﬁned obesity as a BMIZ30. Hypertension diagnosis
was considered if patients were under treatment with at least
one antihypertensive medication including: angiotensin
receptor blocker, ACE inhibitor, beta blocker, alpha adrenergic
blocker, calcium channel blocker and diuretic or systolic
blood pressure4140 mmHg or diastolic blood pressure490.
Measurements were done according to the Seventh Report
[21]. A score on the Epworth sleepiness scale (ESS)410 points
was deﬁned as excessive sleepiness and we used a Peruvian
validation [22]. Finally, T90 was categorised into two groups:
greater than 10% and r10% [23].
2.5. Statistical analysis
We compared the clinical and polysomnographic data of two
control groups (moderate and severe) using t-test for quantita-
tive variables and chi-squared for categorical. The data col-
lected from the case group (Extreme-OSA group) were the
control groups with ANOVA test. We considered a po0.05 value
as signiﬁcant. Next, we performed a conditional logistic regres-
sion model to estimate crude Odds Ratios (crude OR) with a 95%
conﬁdence interval (CI). All analyses were performed with
STATA 12.1 (STATA Corp, College Station, Texas, USA).
2.6. Ethical considerations
We used a coded database and the study did not have any
risk for patients. All patients signed two informed consent
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other one before performing the polysomnography acquisi-
tion. The Clínica Anglo Americana Bioethical Committee of
and the Biomedical Research Ethics Committee (Comité de
Ética en Investigación Biomédica) of the Hospital National
Dos de Mayo (No. 034-2012-CEIB-AI-OACDI-HNDM, 19 May
2012, Lima, Peru) approved the secondary study.3. Results
In our database, we identiﬁed 655 cases of OSA and 22 (0.4%)
patients with an AHIZ100 during a six-year period. Four case
patients were excluded: one for short sleep period time; one for
Goldenhart syndrome diagnosis; one because of comorbid
severe periodic limb movements; and one female patient.
Nineteen case patients that met the inclusion criteria were
matched with 38 moderate OSA controls and 38 severe OSA
controls.
The average age was 48.9713.7 years. Forty-eight (51%)
had arterial hypertension under treatment. Seven (7%)
patients had normal weight, 39 (41%) were overweight, and
10 (11%) suffered from morbid obesity. Forty-three (46%)
patients exhibited sleepiness. Only the greater than 10% in
T90 variable was more frequent in the severe OSA control
group (24%) vs. moderate OSA control group (5%), this
difference was signiﬁcant (po0.01); there were no other
differences between control groups.
The case group had signiﬁcant differences with the control
group in age, weight, BMI, neck circumference, ESS score,
saturation time r90%, and nadir saturation. These variables
had a higher average value in the Extreme-OSA group.
Furthermore, the average age was lower in the Extreme-
OSA group as compared to the control group. Arterial hyper-
tension, sleepiness, and obesity were higher in the Extreme-
OSA group (Table 1).
In the bivariate analysis, T90410% was the variable with
the closest association with Extreme-OSA (crude OR: 19.68,Table 1 – Demographic characteristics of cases (AHI4100) and
Moderate OSA control Se
N¼38 N¼
Age 50.2712.8 51
Weight 88.0719.5 93
Height 173.676.6 17
BMI 29.175.3 30
Neck circumference 42.172.9 42
Epworth scale 10.275.8 9.1
AHI 21.574.3 41
Saturation in W Stage 9771.2 96
Circulation time 1272.1 13
Saturation timer90% of TST (T90) 4.8715.9 8.0
Nadir saturation 83.576.9 81
T90Z10%a 5.26% 23
Sleepinessa 45.95% 35
HBPa 31.58% 52
Obesitya 31.58% 52
Mallampati level IVa 68.42% 68
BMI: body mass index; TST: total sleep time; HBP: high blood pressure.
a Chi-squared.po0.001), followed by obesity (crude OR: 9.29, p¼0.005),
arterial hypertension (crude OR: 6.31, p¼0.006), and, to a
lesser degree, sleepiness, neck circumference, BMI, and
weight. Age and nadir saturation during sleep had an inverse
association with the probability of having Extreme-OSA in the
crude regression models (Table 2).4. Discussion
Our results for the bivariate analysis are consistent with the
associations found in the study conducted by Jurcevic et al.
[13], who included the category of AHIZ60. In the adjusted
analysis, we found that the group with Extreme-OSA has an
increased and consistent association with arterial hyperten-
sion, more time with saturation r90%, and higher neck
circumference. We also found differences in the magnitude
of these associations depending on whether the Extreme OSA
cases were compared with moderate or severe OSA controls,
suggesting that the differences are more notable when
compared with patients with moderate OSA.
The association between arterial hypertension and
Extreme OSA is very high when compared to patients with
severe OSA, and increases even more when compared to
patients with moderate OSA, consistent with the ﬁndings of
the study conducted by Nieto et al. [24], which established
that the probability of arterial hypertension increased
depending on the severity of the OSA. This suggests that
the principal clinical characteristic of patients with Extreme
OSA is that of having a greater probability of arterial hyper-
tension, which is in keeping with other studies that found a
close association between OSA and resistant hypertension
[25], which increased analogously depending on the severity
of the OSA.
While obesity maintained an intense association in the
bivariate analysis (OR: 9.29), this association was lost in the
multivariate analysis, where it was adjusted by neck circum-
ference, which maintained a signiﬁcant association. This iscontrols.
vere OSA control group Extreme-OSA case group p
38 N¼19
.4713.8 41.4713.3 0.023
.0714.8 118.2722.2 o0.001
3.376.4 174.175.3 0.911
.974.5 38.976.9 o0.001
.573.3 47.474.7 o0.001
75.0 13.875.9 0.012
.374.3 110.079.1 o0.001
71.7 9571.5
71.4 1471.2
711.8 33.3726.4 o0.001
.877.7 73.6711.0 o0.001
.68% 73.68% o0.001
.14% 68.42% 0.061
.63% 84.21% o0.001
.63% 89.47% o0.001
.42% 84.21% 0.223
Table 2 – Association between extreme-OSA and demographic characteristics.
Crude OR CI95% p Adjusted ORa CI95% p
HBP 6.31 1.71–23.23 0.006 4.11 1.19–14.1 0.025
Sleepiness 3.39 1.07–10.84 0.039 2.89 0.58–14.47 0.195
Nadir saturation 0.89 0.83–0.96 0.003 0.93 0.86–1.01 0.107
Neck circumference 1.36 1.19–1.53 o0.001 1.16 0.91–1.48 0.219
T90410% 19.68 4.33–89.49 o0.001 1.04 0.98–1.09 0.247
Obesity 9.29 1.99–43.37 0.005 1.62 0.14–18.33 0.699
Weight 1.06 1.02–1.10 0.007 0.99 0.93–1.07 0.887
BMI 1.19 1.06–1.35 0.004 –
Age 0.95 0.92–0.99 0.022 –
HBP: high blood pressure; BMI: body mass index.
a Adjusted OR for BMI and age.
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Framingham study, where they identiﬁed neck circumference
as a variable with an important correlation to obesity, as well
as being associated with cardiovascular risk factors. This
ﬁnding is relevant to the pathogenesis of OSA, since a high
correlation has been identiﬁed between an increase in neck
circumference and AHI value [27]. There is only one reference
in the literature where this population of Extreme sleep
apnoea is distinguished from the other subgroups of severe
sleep apnoea [28], on this paper, the only patients who has
signiﬁcant REM rebound were the patients who has AHI4100
on the baseline portion of sleep study. In our population this
occurrence was not observed.
The primary limitation of the study was related to the low
number of cases identiﬁed by polysomnography in our labora-
tory and for this reason, the conﬁdence intervals were wide.
However, to avoid losing statistical power, we increased the
number of controls to four. Additionally, we were unable to
evaluate all the clinical characteristics of patients with OSA.
The other limitation is the confounding variables related to OSA
consequences like age, and neck circumference, and time
spend with SatO2Hb below 90% for hypertension. The multi-
variable analysis was not possible due to the small sample size.
The limitations described requires speciﬁc studies. Our results
suggest that there is a subgroup of higher severity among
patients with severe OSA that deserves more study.
Patients with Extreme OSA could be associated with a
higher probability of HTA, more time with saturation r90%,
and a higher neck circumference when compared to patients
with moderate OSA, severe OSA, or both. We recommend to
study this population of Extreme OSA for the identiﬁcation of
prognostic variables.Conﬂicts of interest
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